Esper Bionics key facts
- Developer of human augmentation robotic limbs and controllers designed for people with limb differences.
- It has raised $5.0M; the latest was Later Stage VC ($5.0M) in May 2024.
- Notable investors include Google for Startups, Alchemist Accelerator, European Bank for Reconstruction and Development, u.ventures, DMS Accelerator — 9 tracked in total.
- Status: Privately Held (backing).
- ·Watch Esper Bionics: the Monday email on marks, rounds and moves
Esper Bionics funding rounds
No funding rounds for Esper Bionics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Esper Bionics investors
9 investors are on record for Esper Bionics, including Google for Startups, Alchemist Accelerator, European Bank for Reconstruction and Development and u.ventures.
About Esper Bionics
Developer of human augmentation robotic limbs and controllers designed for people with limb differences. The company develops bionic limbs, native control systems, and data-collective architecture for assistive wearables with features such as different sizes, natural shapes, and moves that can automatically change grips to give users faster control in a bionic hand solution, enabling users to enjoy the ease in everyday work.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2019
- Employees
- 70
- Website
- esperbionics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Esper Bionics doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.